Myeloid cell headwinds for GD2-CAR-T cell therapy

Precision Medicine - Have we reached a therapeutic plateau? 2024 and Beyond….

Speakers: Prof Anthony Joshua & Dr Rasha Cosman, St Vincent’s Hospital Sydney Session 3, Talk 3

Dose Ranging and Optimisation in Oncology: Implications for the Design and Conduct of Early Clinical Trials

Speaker: Prof Lesley Seymour, Queens University Kingston Ontario - Session 3, Talk 2

Artificial Intelligence (AI) and Big Data in clinical trials

Speaker: Dr Raanan Berger, Sheba Medical Center Hospital Session 3, Talk 1

Myeloid cell headwinds for GD2-CAR-T cell therapy

Speaker: Prof Michael Brown, Royal Adelaide Hospital Session 2, Talk 2

Developing tumour microenvironment CARs

Speaker: Prof Paul Neeson, Peter MacCallum Cancer Centre - Session 2, Talk 1